Chronic Hepatitis B Special Populations

In this downloadable slideset, Danny Chu, MD, reviews management of HBV in women of childbearing age, strategies for preventing HBV reactivation, monitoring for HCC in the setting of HBV, and other considerations in the management of special populations in patients with HBV infection.
Format: Microsoft PowerPoint (.ppt)
File size: 1.36 MB
Date posted: 4/9/2012
  • Time to Change Our Management Approach in HBV-Immunotolerant Patients?

    Graham R. Foster FRCP, PhD - 1/4/2013    47 comments / Last Comment: 4/27/2014
    New data suggesting that young adults with hepatitis B who have “immunotolerant” disease may actually have very active immune responses raise difficult questions about when to initiate therapy.
  • How Recent Guideline Updates on HBV Screening in HCV-Infected DAA Recipients Affect Clinical Practice

    Norah Terrault MD, MPH - 11/23/2016    1 comment / Last Comment: 11/29/2016
    How do recent AASLD/IDSA updates on HBV screening change nonspecialist and specialist management of HCV patients? Here’s my take.
  • Treating HBV Patients With Cirrhosis: The Need for Vigilant HCC Screening

    Maria Buti MD - 5/14/2014    7 comments / Last Comment: 5/14/2015
    Antiviral therapy can dramatically improve liver histology, even in cirrhotic patients, but it remains critical to screen patients with suppressed viral load for hepatocellular carcinoma.
  • My Approach to Identifying Treatment Candidates and Maintaining Patients on Long-term HBV Therapy

    Anna S. F. Lok MD - 6/19/2014    9 comments / Last Comment: 1/3/2015
    I find it helpful to discuss the impact of treatment on liver fibrosis/cirrhosis and hepatocellular carcinoma with patients, which motivates some to initiate and adhere to their long-term treatment.
  • Coffee May Offer Real Benefits to the Liver

    Mark S. Sulkowski MD - 8/13/2013    8 comments / Last Comment: 5/31/2014
    The latest prescription for liver health in patients with hepatitis: coffee.